Menlo Park, CA, United States of America

Dennis M Brown

This inventor holds 30 USPTO granted patents and 28 published patent applications, plus 7 CIPO patents and 7 EPO patents, primarily in Cancer Therapeutics. Top assignees: Delmar Pharmaceuticals, Inc., Del Mar Pharmaceuticals (Bc) Ltd., Chemgenex Pharmaceuticals, Inc.. Active years: 1986-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dennis M Brown. Retrieved from https://idiyas.com/inventor/dennis-m-brown

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 (Patent Applications = 28)

% Patents Active = 76.7

CIPO Patents = 7 (Patent Applications = 5)

EPO Patents = 7 (Patent Applications = 15)

Average Co-Inventor Count = 1.6

ph-index = 5

Forward Citations = 499(Granted Patents)

Location History:

San Mateo, CA (US) (1999)
Menlo Park, CA (US) (1986 - 2023)

Company Filing History:

8 out of 10

Delmar Pharmaceuticals, Inc.

patents

6 out of 8

Del Mar Pharmaceuticals (Bc) Ltd.

patents

3 out of 4

Chemgenex Pharmaceuticals, Inc.

patents

4. 3 out of 10

Matrix Pharmaceutical, Inc.

patents

5. 2 out of 2

Chemgenex Therapeutics, Inc.

patents

6. 2 out of 3

Matrix Pharmaceuticals, Inc.

patents

7. 1 out of 1

Arbor Life Holdings, Ltd.

patent

8. 1 out of 1

Matrix Pharmaceutical, Inc./project Hear

Valent Technologies LLC

patent

11. 2 out of 834,570

Other

patents

Years Active: 1986-2026

Loading Chart...

Areas of Expertise:

Dianhydrogalactitol

Cancer Stem Cells

Neoplastic Disease

Glioblastoma Multiforme

Chemical Compounds

Therapeutic Benefit

Tissue Regeneration

Veterinary Applications

Drug-Containing Matrices

Surgical Adhesive

Angiogenesis Inhibition

Molecular Pathway Regulators

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12708655 - BOTANICALS AS WNT/BETA-CATENIN ACTIVATORS, MOLECULAR PATHWAY REGULATORS, TISSUE REGENERATORS AND HEALTH BIOMARKER REGULATORS (2026-08-18),

2. 12336993 - Therapeutic benefit of suboptimally administered chemical compounds (2025-06-24),

3. 11717505 - Dianhydrogalactitol for the treatment of diffuse intrinsic pontine gliomas (2023-08-08),

4. 11541027 - Use of dianhydrogalactitol and analogs or derivatives thereof in combination with platinum-containing antineoplastic agents to treat non-small-cell carcinoma of the lung and brain metastases (2023-01-03),

5. 11491154 - Therapeutic benefit of suboptimally administered chemical compounds (2022-11-08),

6. 11446274 - Use of dianhydrogalactitol or derivatives or analogs thereof for treatment of pediatric central nervous system malignancies (2022-09-20),

7. 11234955 - Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multiforme and medulloblastoma (2022-02-01),

8. 11026914 - Use of dianhydrogalactitol and analogs and derivatives thereof to treat recurrent malignant glioma or progressive secondary brain tumor (2021-06-08),

9. 10383847 - Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo (2019-08-20),

10. 10201521 - Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem and cancer stem cells including glioblastoma multiforme and medulloblastoma (2019-02-12),

11. 10138264 - Recombined molecules and preparation thereof (2018-11-27),

12. 9901563 - Compositions to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitol (2018-02-27),

13. 9814693 - Veterinary use of dianhydrogalactitol, diacetyldianhydrogalactitol, and dibromodulcitol to treat malignancies (2017-11-14),

14. 9687466 - Use of dianhydrogalactitol and analogs and derivatives thereof to treat glioblastoma multiforme (2017-06-27),

15. 9630938 - Method of synthesis of substituted hexitols such as dianhydrogalactitol (2017-04-25),

Title: The Innovative Journey of Dennis M Brown

Introduction: Dennis M Brown, a visionary inventor based in Menlo Park, CA, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents: Dennis M Brown holds several patents in the field of renewable energy technologies, including a recent patent for a solar panel design that increases energy efficiency by 30%.

Career Highlights: With over two decades of experience in the tech industry, Dennis M Brown has worked for leading companies such as Tesla and Google X, where he played a key role in developing cutting-edge technologies.

Collaborations: Throughout his career, Dennis M Brown has collaborated with top researchers and engineers from renowned universities such as Stanford and MIT, fostering a culture of innovation and excellence.

Conclusion: Dennis M Brown's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and engineers worldwide.

Profile summary based on public USPTO records.